Non-Adherence to Anti-Hypertensive Treatment
DOI:
https://doi.org/10.47203/IJCH.2020.v32i01.025Keywords:
Adherence, Anti-Hypertensive Treatment, HypertensionAbstract
Background: In developed countries, adherence among patients suffering from chronic diseases averages only 50%; in developing countries it is assumed to be much lower. Aims & objectives: To find out the prevalence of non-adherence to antihypertensive treatment among individuals seeking anti-hypertensive treatment from tertiary care hospital in New Delhi & to find out the factors related to non-adherence to the anti-hypertensive treatment among study subjects. Material and Methods: A cross-sectional hospital-based study was conducted from June to October 2018 among 150 diagnosed cases of hypertension. The drug adherence was assessed by using standard Brief Medication Questionnaire I (BMQ I) and to know the determinants of non-adherence a semi-structured (self-designed and pre tested) questionnaire was used. The association of different factors with adherence was analyzed by applying chi square (?2) test. Results: Among total of 150 participants 44% were males and 56% were females. The magnitude of non-adherence to anti-hypertensive drugs was 35.3%. Side effects of anti-hypertensive drugs was significant risk factor for non-adherence to anti-hypertensive drugs and common reasons for non-adherence were unwanted side effects (64.2%) followed by worry about long term side effects (62.3%). Conclusion: Prevalence of non-adherence to anti-hypertensive drugs was quite high, most common reason for non-adherence to anti-hypertensive medication was unwanted side effects and worry about long term side effects.
Downloads
References
Magnusson RS. Non-communicable diseases and global health governance: enhancing global processes to improve health development. Globalization and Health 2007; 3: 2.
World Health Statistics 2017: monitoring health for the SDGs, Sustainable Development Goals. Geneva, World Health Organization, 2017. Available on https://www.who.int/gho/publications/world_health_statistics/2017/EN_WHS2017_TOC.pdf?ua=1 (Accessed on 15/10/2019)
Non-communicable Diseases Progress Monitor, 2017. Geneva: World Health Organization; 2017. Available on https://apps.who.int/iris/bitstream/handle/10665/258940/9789241513029-eng.pdf;jsessionid=3A705CEE93CBCA1D2AEC3472A8CB02B0?sequence=1 (Accessed on 15/10/2019)
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-based Studies from 90 Countries. Circulation 2016; 134(6): 441-50.
Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014; 32:1170–7.
Strasser T. (1972). WHO Chronicle, 26: 451.
Haynes RB. Determinants of compliance: The disease and the mechanics of treatment. Baltimore MD, Johns Hopkins University Press, 1979.
Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol 1993;72(10):68D-74D.
Sackett DL, Haynes RB, Gibson ES, Taylor DW, Roberts RS, Johnson AL. Patient compliance with antihypertensive regimens. Patient Couns Health Educ 1978;1(1):18-21.
Leupkar RV. Patient adherence: A "risk factor" for cardiovascular disease. The Framington Study. JAMA1971; 215:1617-25.
Moreira L, Fernandes P, Monte S, Martins A. Medication Compliance in Patients with Chronic Kidney Disease. J Nephrol 2008;21(3):354-62.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353(5):487-497.
Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med 2006;166(17):1855-62.
Mantovani MDF, Mattei AT, Arthur JP, Ulbrich EM, Moreira RC. The use of the brief medication questionnaire in medication accession of hypertensives. J Nurs 2015; 9(1):84-90.
Roy NT, Sajith M, Bansode MP. Assessment of Factors Associated with Low Adherence to Pharmacotherapy in Elderly Patients. J Young Pharm. 2017;9(2):272-6.
Berisa HD, Dedefo MG. Non-adherence related factors to antihypertensive medications among hypertensive patients on follow up at nedjo general hospital in West Ethiopia. Open Pub Health J 2018; 11: 62-71.
Gupta MC, Bhattacharjee A, Singh H. Evaluation of medication adherence patterns amongst anti-hypertensive drug users in a tertiary care hospital in north India. Int J Basic Clin Pharmacol 2016; 5:2261-6.
Sahoo SK, Preeti PS, Biswas D. Adherence to Anti-Hypertensive Drugs: A Clinic Based Study among Geriatric Hypertensive Patients in Rural, India. Natl J Community Med 2018; 9(4): 250- 54.
Kazaure AZ, Abubakar AA, Ibrahim MS, Gidado S, Sabitu K, Nguku P. Factors for nonadherence to antihypertensive drugs among Federal Civil Servants attending health facilities???Abuja, FCT. Sub-Saharan African Journal of Medicine Jan-March 2017;4(1):20-25.
Balasubramanian A, Nair SS, Rakesh PS, Leelamoni K. Adherence to treatment among hypertensives of rural Kerala, India. J Family Med Prim Care 2018; 7:64-9.
Mekonnen HS, Gebrie MH, Eyasu KH, Gelagay AA. Drug adherence for antihypertensive medications and its determinants among adult hypertensive patients attending in chronic clinics of referral hospitals in Northwest Ethiopia. BMC PharmacolToxicol 2017; 18: 27.
Hashmi SK, Afridi MB, Abbas K, Sajwani RA, Saleheen D, Frossard PM, et al. Factors associated with adherence to anti-hypertensive treatment in Pakistan. PLoS One. 2007;2: e280.
Downloads
Published
How to Cite
License
Copyright (c) 2020 Indian Journal of Community Health
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
